Ptc Therapeutics PTCT
NASDAQ PTCT
$65.00 -0.95 (-1.44%)
As of: Sep 29, 2026 · 3:59 PM EDT

Ptc Therapeutics (PTCT) Net Margin (2012 - 2026)

Updated

Ptc Therapeutics (PTCT) posted Net Margin of 23.16% for Q2 2026, up 59.41 percentage points from -36.25% a year earlier and up 24.19 percentage points from the prior quarter.

Analysis

Ptc Therapeutics (PTCT) Net Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Ptc Therapeutics was -3.80%, down 39.45 percentage points year-over-year; for FY2025, it was 39.44%, up 84.47 percentage points from FY2024.

  • Annual Net Margin has increased for five consecutive years, with a five-year change of +154.52 percentage points (FY2020 to FY2025).
  • In prior years, Ptc Therapeutics' Net Margin was -45.03% in FY2024 (+21.78 pp), -66.81% in FY2023 (+13.18 pp), -80.00% in FY2022 (+17.28 pp) and -97.27% in FY2021 (+17.80 pp).
  • The Q2 2026 figure stands as the highest quarterly Net Margin since Q1 2025.
  • On a year-over-year basis, Net Margin increased in six of the last eight quarters, with an average year-over-year change of +20.35 percentage points.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q1 2025, with a gain of 117.26 percentage points; the weakest was Q1 2026, with a drop of 74.71 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -1.03% (Q1 2026), -81.96% (Q4 2025) and 7.53% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Ptc Therapeutics 5.50 Bn -2.26 Bn 340.60 Mn 23.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.16%
Mar 31, 2026 -1.03%
Dec 31, 2025 -81.96%
Sep 30, 2025 7.53%
Jun 30, 2025 -36.25%
Mar 31, 2025 73.68%
Dec 31, 2024 -30.91%
Sep 30, 2024 -54.20%
Jun 30, 2024 -53.12%
Mar 31, 2024 -43.58%
Dec 31, 2023 -50.74%
Sep 30, 2023 -67.64%
Jun 30, 2023 -93.02%
Mar 31, 2023 -63.05%
Dec 31, 2022 -102.08%
Sep 30, 2022 -50.35%
Jun 30, 2022 -91.88%
Mar 31, 2022 -85.20%
Dec 31, 2021 -86.71%
Sep 30, 2021 -96.31%
API Access

Ptc Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=PTCT&period=max&api_key=YOUR_API_KEY